Publications
The Farm System Reform Act would halt construction of new concentrated animal feeding operations (CAFOs) and phase out all large CAFOs by 2040, while also holding corporate meatpackers more accountable for environmental degradation and farmer exploitation.
Read MoreToday, the Open Markets Institute filed an amicus curiae brief in the Fifth Circuit Court of Appeals in support of the Federal Trade Commission (FTC) in its suit against generic drug maker Impax Laboratories.
Read More“Open Markets has long called for reinvigorating the Packers & Stockyards Act," said Open Markets Institute's Food & Power Reporter Claire Kelloway. "This is a transformative step in challenging Big Ag’s monopoly power.”
Read MoreOn December 16, 2019, Open Markets Institute filed an amicus curiae brief in the Fifth Circuit Court of Appeals in support of the Federal Trade Commission (FTC) in its suit against generic drug maker Impax Laboratories.
Read MoreThe New York Times' Natasha Singer "reviews the week’s news, offering analysis about the most important developments in the tech industry." She cites Open Markets' Researcher and Reporter Matthew Buck's piece on the Washington Monthly, which argues that Amazon, Google and Facebook should stay out of health care, among "Stories You Shouldn't Miss."
Read MoreThe Washington Post's Tony Romm reports that regulators probing Facebook for violations of antitrust law have considered seeking a preliminary injunction against the company, aiming to halt the tech giant’s plans to integrate its social-networking app with the other services it owns. “At a time when Facebook is under scrutiny for its monopoly power and its abuses of its power, to say it’s going to integrate these three platforms is just another monopoly grab,” Open Markets Director of Enforcement Strategy Sally Hubbard told him.
Read MoreWhite Paper: The Role of Monopoly in America’s Prescription Drug Crisis | White Paper: The Role of Hospitals in America’s Health Care Crisis
Read MoreTony Romm of The Washington Post reports on the federal investigation of Facebook’s antitrust violations and quotes Sally Hubbard, director of enforcement strategy at Open Markets Institute, opposing Facebook’s talk of integrating Facebook, Instagram, and WhatsApp.
Read MoreRoger Parloff reports in Yahoo! Finance about the antitrust backlash against Big Tech and credits Open Markets Institute for elevating the issue and changing the debate.
Read MoreOn Yahoo Finance, Roger Parloff tells the story of how America has come to a turning point in its views of antitrust. He tracks the origins of the progressive neo-Brandesian movement and how key figures have played leading roles in igniting the Big Tech antitrust backlash in Washington including Tim Wu, Barry Lynn, Lina Khan, Matt Stoller, and Luther Lowe. Parloff quotes Former FTC chair William E. Kovacic who commented: "In five years, Barry and his group have changed the debate. They’ve gone from being a largely unnoticed fringe body of commentary to being at the very center of the debate.”
Read MoreThis report, “The Role of Monopoly in America’s Prescription Drug Crisis,” exposes how big pharma drives up drug costs through patent monopolies, abuses of regulations, and corporate consolidation.
Read MoreAs Rep. Nancy Pelosi prepares for a showdown in Congress over her Lower Drug Costs Now bill, Open Markets Institute today released The Role of Monopoly in America’s Prescription Drug Crisis.
Read MoreBaldwin, Florida, a town of roughly 1,600 residents west of Jacksonville, lost its last grocery store in 2018, writes Claire Kelloway. Baldwin’s store resembles other collective and community-driven efforts to combat rural food deserts, which were partly created by predatory big-box stores. It also revives a forgotten notion that government should provide open and accessible food markets, which were a central part of municipal planning and responsibility through the 19th century.
Read MoreThis report, published in 2019, investigates an often-overlooked factor behind high prices for medical services: the increasing corporate concentration of ownership, particularly among hospitals.
Read MoreToday, the Open Markets Institute released The Role of Hospital Monopolies in America’s Health Care Crisis, which presents insights into how the astronomically high cost of health care in the United States is a result of increasing corporate concentration of hospital ownership.
Read MoreIn the biggest government antimonopoly case since Microsoft, Open Markets filed an amicus brief in the Ninth Circuit Court of Appeals in support of the Federal Trade Commission (FTC) in its suit against Qualcomm.
Read More"Importing drugs won’t bring prices down significantly because it fails to address the root cause of the problem: monopoly," said Open Markets Managing Editor Michael Bluhm in a statement today.
Read MoreOpen Markets Food & Power researcher and reporter Claire Kelloway published an op-ed on the Washington Monthly on November 21, 2019 on how America’s biggest dairy co-op is trying to become even bigger. Kelloway writes that one critical reason dairy farms feel pressure to consolidate is because milk retailers, buyers, and, processors have spent years consolidating around them. Now, a merger between major milk monopolists threatens to deal another blow to ailing dairy farmers, and its not clear if federal enforcers will do anything to stop it.
Read More
